ConductScience.org, home

Paper39025943

Radiotherapy-triggered reduction of platinum-based chemotherapeutic prodrugs in tumours.

Fu Q and 12 others. Nat Biomed Eng, 2024. Cited by 50 papers, by iCite.

Cite this record

ConductScience Library. Radiotherapy-triggered reduction of platinum-based chemotherapeutic prodrugs in tumours. Papers, record 39025943. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39025943

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Radiotherapy-triggered reduction of platinum-based chemotherapeutic prodrugs in tumours.
PubMed
Journal
Nat Biomed Eng
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
50
iCite
Relative citation ratio, by iCite
6.57, provisional
iCite
Revised in PubMed
2026-09-11
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fu QQunfeng
2Zhang SShuren
3Shen SSiyong
4Gu ZZhihttps://orcid.org/0009-0009-4225-6892
5Chen JJunyi
6Song DDongfan
7Sun PPengwei
8Wang CChunhong
9Guo ZZhibin
10Xiao YYunlong
11Gao YQYi Qin
12Guo ZZijianhttps://orcid.org/0000-0003-4986-9308
13Liu ZZhibohttps://orcid.org/0000-0002-5587-4165

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ProdrugsMajor topic
Antineoplastic AgentsMajor topic
Animals
Humans
Mice
Cell Line, Tumor
Platinum
Xenograft Model Antitumor Assays
Neoplasms
Oxaliplatin
Female
Trastuzumab
Mice, Nude
Organoplatinum Compounds
Tumor Microenvironment

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
22225603National Natural Science Foundation of China (National Science Foundation of China)PubMed
21731004National Natural Science Foundation of China (National Science Foundation of China)PubMed
91953201National Natural Science Foundation of China (National Science Foundation of China)PubMed
2021YFA1601400Ministry of Science and Technology of the People's Republic of China (Chinese Ministry of Science and Technology)PubMed
Z200018Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation)PubMed

Source PubMed

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in42722903Author Correction: Radiotherapy-triggered reduction of platinum-based chemotherapeutic prodrugs in tumours.https://conductscience.org/library/papers/42722903

Source PubMed

Download CSV of comments and corrections

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132843739Artificial intelligence in radiation oncology.Nat Rev Clin Oncol2020https://conductscience.org/library/papers/32843739PubMed
230792503Radiotherapy toxicity.Nat Rev Dis Primers2019https://conductscience.org/library/papers/30792503PubMed
315170446Exploiting tumour hypoxia in cancer treatment.Nat Rev Cancer2004https://conductscience.org/library/papers/15170446PubMed
426105538The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence.Nat Rev Cancer2015https://conductscience.org/library/papers/26105538PubMed
514645636Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.N Engl J Med2003https://conductscience.org/library/papers/14645636PubMed
624889915Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxics.Eur J Cancer2014https://conductscience.org/library/papers/24889915PubMed
729700501The expanding role of prodrugs in contemporary drug design and development.Nat Rev Drug Discov2018https://conductscience.org/library/papers/29700501PubMed
826865551The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.Chem Rev2016https://conductscience.org/library/papers/26865551PubMed
919711978Platinum drug distribution in cancer cells and tumors.Chem Rev2009https://conductscience.org/library/papers/19711978PubMed
1030299085Stimuli-Responsive Therapeutic Metallodrugs.Chem Rev2019https://conductscience.org/library/papers/30299085PubMed
1122248856Reductive activation of 5-fluorodeoxyuridine prodrug possessing azide methyl group by hypoxic X-irradiation.Bioorg Med Chem Lett2012https://conductscience.org/library/papers/22248856PubMed
1234112990Switching on prodrugs using radiotherapy.Nat Chem2021https://conductscience.org/library/papers/34112990PubMed
1335594148Radiotherapy Reduces N-Oxides for Prodrug Activation in Tumors.J Am Chem Soc2022https://conductscience.org/library/papers/35594148PubMed
1431919219Observation of the fastest chemical processes in the radiolysis of water.Science2020https://conductscience.org/library/papers/31919219PubMed
1512767396Decomposition of an aqueous solution of [11C]Ro 15-4513: implication of hydrated electrons in the radiolysis of [11C]Ro 15-4513.Nucl Med Biol2003https://conductscience.org/library/papers/12767396PubMed
1629048884Nanotechnology for Multimodal Synergistic Cancer Therapy.Chem Rev2017https://conductscience.org/library/papers/29048884PubMed
1723042411Targeting and delivery of platinum-based anticancer drugs.Chem Soc Rev2013https://conductscience.org/library/papers/23042411PubMed
1832216337A Photocaged, Water-Oxidizing, and Nucleolus-Targeted Pt(IV) Complex with a Distinct Anticancer Mechanism.J Am Chem Soc2020https://conductscience.org/library/papers/32216337PubMed
1929509010Insight into the Electrochemical Reduction Mechanism of Pt(IV) Anticancer Complexes.Inorg Chem2018https://conductscience.org/library/papers/29509010PubMed
2024853204
Understanding intrinsically irreversible, non-Nernstian, two-electron redox processes: a combined experimental and computational study of the electrochemical activation of platinum(IV) antitumor prodrugs.
J Am Chem Soc2014https://conductscience.org/library/papers/24853204PubMed

See all 28 referencesDownload CSV of references

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.

PMIDTitleJournalYearIn PapersSource
42958328A platinum-osmium hybrid nanozyme potentiates chemo-radio-immunotherapy for colorectal cancer via tumor microenvironment remodeling and cGAS-STING activation.J Nanobiotechnology2026https://conductscience.org/library/papers/42958328PubMed
42592132Nanocarrier-based delivery of Pt(IV) compounds for chemoimmunotherapy and theranostics: Advances, challenges, and prospects.Acta Pharm Sin B2026https://conductscience.org/library/papers/42592132PubMed
42503675Spontaneous Intracellular Formation of Covalent Organic Frameworks via Enzyme-Initiated Cascade Reactions to Boost Cancer Radiotherapy.J Am Chem Soc2026https://conductscience.org/library/papers/42503675PubMed
42500932A Multiple Enzyme-Mimetic Platinum-Ruthenium Nanohybrid Prodrug Potentiates Chemo-/Chemodynamic-/Immuno-Therapy of Hypoxic Tumors.Adv Healthc Mater2026https://conductscience.org/library/papers/42500932PubMed
42255197Uncoupling tumor immunogenicity from cell death with platinum(IV)-antibody conjugates.Natl Sci Rev2026https://conductscience.org/library/papers/42255197PubMed
42078200Radiotherapy meets anticancer metallodrugs.Med Rev (2021)2026https://conductscience.org/library/papers/42078200PubMed
42001063Single-dose X-ray driven persistent activation of nanoprodrugs for radio-chemo-immunotherapy.J Nanobiotechnology2026https://conductscience.org/library/papers/42001063PubMed
41821152Engineering MnPt Bimetallic Nanozymes for Cascade Enzymatic Therapy and Enhanced Radio-Immunotherapy.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41821152PubMed
41516303Lanthanide Nanotheranostics in Radiotherapy.Int J Mol Sci2025https://conductscience.org/library/papers/41516303PubMed
41398312The role of ionizing radiation-initiated reactions in targeted activation of chemotherapeutics.Nat Rev Chem2026https://conductscience.org/library/papers/41398312PubMed
41332239Ruthenium Complexes in Protein Science: Heading a New Generation of Therapeutic and Analytical Tools.Angew Chem Int Ed Engl2026https://conductscience.org/library/papers/41332239PubMed
41202204Rate-Tunable, Metal-Mediated Amide Bond Cleavage for the Controlled Release of Pharmaceuticals.J Am Chem Soc2025https://conductscience.org/library/papers/41202204PubMed
41121609Controlled Dual Activation of Rhenium(I) Photosensitizers and Profluorophores/Prodrugs via a Dissociative Bioorthogonal Tetrazine-Isonitrile Reaction.Angew Chem Int Ed Engl2025https://conductscience.org/library/papers/41121609PubMed
40985211Colorectal Cancer at the Crossroads: The Good, the Bad, and the Future of Platinum-Based Drugs.Chem Rev2025https://conductscience.org/library/papers/40985211PubMed
40927152Improving Brain Tumor Treatment through Nanotechnology and Proton Therapy Using Laser-driven Accelerators through GEANT4 Simulation.Indian J Nucl Med2025https://conductscience.org/library/papers/40927152PubMed
40893960Radiotherapy-Activated Prodrug: Past, Present and Beyond.ACS Cent Sci2025https://conductscience.org/library/papers/40893960PubMed
40747318Novel tryptophan 2,3-dioxygenase-targeted ruthenium(ii)-indole complex activates immunotherapy in vitro and in vivo.Chem Sci2025https://conductscience.org/library/papers/40747318PubMed
40592827Single atom engineering for radiotherapy-activated immune agonist prodrugs.Nat Commun2025https://conductscience.org/library/papers/40592827PubMed
40563367Oxidative Stress and Inflammation: Drivers of Tumorigenesis and Therapeutic Opportunities.Antioxidants (Basel)2025https://conductscience.org/library/papers/40563367PubMed
40177396Alkyl Chloride-Functionalized Polymers Mediate Oxidation of Thioethers Initiated by Ionizing Radiation.ACS Appl Polym Mater2025https://conductscience.org/library/papers/40177396PubMed

See all 25 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39025943

GET https://conductscience.org/api/papers/v1/39025943/references?page=2